Clinical Trial Services & Solutions Sourcing Center
According to the Alliance of Regenerative Medicine, there were 1,220 clinical trials ongoing at the end of 2020, with 152 of those trials in Phase 3, supporting the FDA’s and EMA’s predictions they will approve 10-20 cell and gene therapies each year by 2025.
The development of cell and gene therapy trials is both complex and challenging as well as subject to heavy regulatory scrutiny. As new and emerging biotechs and even established pharma drive their research forward through clinical trials, anticipating challenges can be key to bringing therapies from bench to bedside. Biotechs will be faced with important decisions when it comes to clinical development and selecting the right CRO partner is one of those decisions.
How can we help?
Looking for help with your Cell & Gene Therapy clinical trial? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
Egnyte for Life Sciences is a unified data collaboration platform to serve those advancing the science of health. The advanced platform supports features designed to maintain regulatory compliance, support secure sharing, and manage data governance. More than 16,000 businesses, and more than 400 life science organizations, trust Egnyte to provide visibility and control into their most valuable asset, their data.
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
Precision ADVANCE is a collection of interconnected services and complementary teams uniquely focus on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market. Learn more about how we accelerate clinical development with Precision for Medicine, optimize next-gen manufacturing with Project Farma and drive commercial success with Precision Value & Health.
Premier Research is a clinical research organization that leverages leading technologies and predictive recruitment models so our teams can build statistical, adaptive approaches and find efficiencies that support Fast Track designation and orphan drug status. Our Built for Biotech model is a compilation of the most successful techniques and capabilities observed across our experience, applied to meet your highly specific needs.
Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years’ experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years alone.